Genome-wide localization of small molecules

Area of Science:

• Genomics
• Chemical Biology
• Drug Discovery

Background:

• Small-molecule ligands, including therapeutics, exert effects by binding genome-associated proteins.
• Understanding these interactions genome-wide is crucial for deciphering chemical perturbation of cellular functions.

Purpose of the Study:

• To introduce and validate Chem-seq, a method for genome-wide mapping of small-molecule binding sites.
• To demonstrate the utility of Chem-seq in combination with ChIP-seq for studying drug-target interactions in tumor cells.

Main Methods:

• Ligand-affinity capture coupled with massively parallel DNA sequencing (Chem-seq).
• Integration of Chem-seq with Chromatin Immunoprecipitation sequencing (ChIP-seq).

Main Results:

• Chem-seq successfully identifies genome-wide binding sites for small chemical molecules.
• Combined Chem-seq and ChIP-seq provide unique insights into drug-target protein interactions within the genome of tumor cells.

Conclusions:

• Chem-seq is a powerful tool for characterizing the specificity of chemical entities interacting with DNA or associated proteins.
• These methods will significantly enhance the understanding of therapeutic action and drug specificity.